Approvals/CIMA-AEMPS/ICATIBANTO GLENMARK 30 MG SOLUCION INYECTABLE EN JERINGA PRECARGADA EFG

Approved

STANDARD

ICATIBANTO GLENMARK 30 MG SOLUCION INYECTABLE EN JERINGA PRECARGADA EFG

Glenmark Arzneimittel Gmbh🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Id: c0779f47f7131d4e
Drug Cima Aemps Name: ICATIBANTO GLENMARK 30 MG SOLUCION INYECTABLE EN JERINGA PRECARGADA EFG
Register Number: 86480
Holder Company Name: Glenmark Arzneimittel Gmbh
Marketing Company Name: Glenmark Farmaceutica S.L.U
Holder Company Detail Path: /organization/glenmark-arzneimittel-gmbh
Authorization Date: 2021-12-28
Dosage Form: SOLUCIÓN INYECTABLE EN JERINGA PRECARGADA
Dose: 30 mg/3 ml
Route Of Administration: VÍA SUBCUTÁNEA
Prescription Type: Uso Hospitalario
Commercialized: Yes
Company Name: Glenmark Arzneimittel Gmbh
Company Detail Path: /organization/glenmark-arzneimittel-gmbh

ICATIBANTO ACETATO

35,52 mg

Approved

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Dec 28, 2021

Approval ID

c0779f47f7131d4e

Type

Standard